This is the leaflet Dr gave me.
Electrosclerotherapy in Vascular Malformations
Introduction
Vascular malformations are congenital anomalies of the vascular system which can represent a therapeutic challenge, particularly in patients with recurrent or therapy-resistant malformations.
Current management consists of intralesional sclerotherapy techniques.
However, its effectiveness has been limited and often requires several treatment sessions.
Electrosclerotherapy is a cutting edge treatment for venous and lymphatic malformations.
Electrosclerotherapy
Electrosclerotherapy consists of the application of short term, high intensity electrical pluses that transient permeabilisation of cell membranes (reversible electroporation), thus facilitating the intercellular delivery of an otherwise poorly permeant sclerosing agent.
Reversible electroporation induces the temporary disruption of cytoskeletal structures of endothelial cells and significantly enhances the effect of the sclerosing agent. Furthermore, electrical impulses have an important immediate vascular effect (vascular lock) that reduces blood flow transiently and prevents bleeding.
How effective is electrosclerotherapy?
A recent observational study conducted in 17 patients with therapy-resistant symptomatic venous malformation showed remarkable clinic effectiveness of electrosclerotherapy, with 8 patients becoming asymptomatic and 9 patients showing improvement after treatment.
These favourable results were achieved after only one electrosclerotherapy treatment session in 88% of the patients.
The median applied dose was 3 mg, which represents an additional advantage: lowing the risk of side effects related to a high cumulative dose.
The median volume reduction following electrosclerotherapy measured on MRI images was 86%.
Beyond the limits with Electrosclerotherapy
HIGHER EFFECTIVENESS
FEWER TREATMENT SESSIONS
REDUCED DOSE OF SCLEROSING AGENT
MINIMAL SIDE EFFECTS